Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. embryon

EMBRYON

EMBRYON - Develop and commercialize a highly innovative diagnostic-imaging product, improving success rates in the Assisted Reproduction IVF sector

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 EMBRYON project word cloud

Explore the words cloud of the EMBRYON project. It provides you a very rough idea of what is the project "EMBRYON" about.

switzerland    births    45    subjective    issue    revenues    scientists    extension    fda    precision    algorithms    15    embryos    easier    compliant    reproductive    2020    1400    microscopy    morphological    100    software    finalize    favoring    physician    stressful    patented    generation    leader    costly    fertilization    rates    billion    org    imaging    innovation    partnership    forecasts    cycle    publish    2013    shape    optimization    reactivity    rate    embryon    ph2    specialists    last    cycles    transferred    ww    observations    image    clearance    units    market    ph1    gross    patents    scan    identification    diagnostic    ivf    couples    certify    10    outcomes    infertility    improves    ethical    introduces    deeper    favored    regulation    instruments    innovations    trials    double    social    global    proprietary    invasive    vitro    million    procedure    patients    approximate    big    heavy    20    italy    dollars    ll    validated    1200    therapy    leaving    predictors    commercial    ce    microscope    validation    despite    pregnancy    lifetime    nearly    six    simpler    ongoing    handcrafted    amongst    patterns    overcoming    merges    solutions    nikon    smarter    sales    plan    utero    prototype    acs    automated    safer    clinics    newco    deep    embryo    clinical    lab    images    cheaper   

Project "EMBRYON" data sheet

The following table provides information about the project.

Coordinator		 ADVANCED COMPUTER SYSTEMS A.C.S. SPA 

Organization address
address: VIA DELLA BUFALOTTA 378
city: ROMA
postcode: 139
website: www.acsys.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Italy [IT]
 Project website http://www.unbimbo.it/en/index.html
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2015-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ADVANCED COMPUTER SYSTEMS A.C.S. SPA IT (ROMA) coordinator 50˙000.00

Map

 Project objective

Infertility is a heavy social issue,experienced by nearly one in six couples during reproductive lifetime. In Vitro Fertilization (IVF) is growing 8-10% p.a.,to 1.5 million therapy cycles and 7.5 billion dollars in 2013. Despite stressful and costly procedures,IVF success rate is low (15-20% births/cycle),leaving big opportunities for innovation and process optimization. EMBRYON introduces to IVF clinics and specialists a last-generation diagnostic-imaging system,favoring better outcomes through deeper,smarter analysis of clinical images. It merges tailored image-processing software and algorithms,patented by ACS,with a high-end commercial IVF microscope.A prototype is under validation with top clinics in Italy and Switzerland,supported by Nikon Instruments (global leader in IVF microscopy). EMBRYON improves the key success factor of any IVF procedure:the identification of 1-2 embryos with best “pregnancy potential” to be transferred in utero,amongst 5-10 generated in vitro. EMBRYON’s precision is double than current handcrafted approaches,favoring higher success rates. It is safer (100% not invasive),thus simpler to certify and adopt,fully compliant with ethical regulation,easier to use (no change to lab procedures) and cheaper than similar products. Key innovations 1. Automated deep scan of embryo shape,overcoming today’s subjective and approximate observations carried by the physician 2. Proprietary algorithms for the measurement of complex morphological patterns,strong predictors of potential Sales forecasts are 1200-1400 units (40-45 M€ gross revenues) by 2020 in Europe and US,favored by: - High reactivity of the IVF sector (scientists/patients) to validated solutions improving outcomes - Commercial partnership with a global IVF microscopy leader In Ph1 we’ll finalize and publish the ongoing clinical studies and make a deep market analysis for Europe-US In Ph2 we plan CE/FDA clearance,WW extension of patents,3 trials in Europe-US,set-up of newco and sales org

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EMBRYON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EMBRYON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

RESHAPE (2019)

Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More